| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/28/2010 | US20100022450 Octreotide implant having a release agent |
| 01/28/2010 | US20100021529 Step-down estrogen regimen for women receiving estrogen therapy |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | DE102008034739A1 Preparation, useful for the treatment of equine Cushing's syndrome, comprises allopurinol |
| 01/28/2010 | CA2731634A1 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 01/27/2010 | EP2147924A1 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 01/27/2010 | EP2147922A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/27/2010 | EP2147014A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/27/2010 | EP2146741A2 Medicaments and methods to treat autoimmune disease and cancer |
| 01/27/2010 | CN100584314C Composition having gelling properties for the prolonged delivery of bioactive substances |
| 01/26/2010 | US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7651703 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 01/26/2010 | US7651656 Melting furnace with agitator and agitator for melting furnace |
| 01/26/2010 | CA2642066C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 01/26/2010 | CA2505575C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2009135651A8 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 01/21/2010 | WO2009128936A3 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 01/21/2010 | WO2009056569A9 Lh liquid formulations |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | CA2730933A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/14/2010 | WO2010006236A1 Delivery of dry formulations of octreotide |
| 01/14/2010 | WO2010004299A2 Composition |
| 01/14/2010 | WO2010003170A1 Novel receptor hetero-dimers/-oligomers |
| 01/14/2010 | WO2009138186A3 SEQUENTIAL ADMINISTRATION OF 20,20,21,21-PENTAFLUORO-17-HYDROXY-11β-[4-(HYDROXYACETYL) PHENYL] -19-NOR-17α-PREGNA-4,9-DIENE-3-ONE AND ONE OR MORE PROGESTATIONAL HORMONES FOR TREATING GYNAECOLOGICAL DISEASES |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009899 Novel Insulin Derivatives |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | CA2730391A1 Delivery of dry formulations of octreotide |
| 01/14/2010 | CA2730325A1 Composition |
| 01/13/2010 | EP2143724A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142528A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
| 01/13/2010 | EP2142194A1 Mineralocorticoid receptor antagonists |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | CN100579979C 7-phenylpyrazolopyridine compounds |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | CA2468412C 17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediates for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010000066A1 Diglycidic ether derivative therapeutics and methods for their use |
| 01/07/2010 | WO2010000025A1 Anti-pamp therapeutic antibodies |
| 01/07/2010 | WO2010000011A1 The use of androgens for vascular regeneration and endothelial repair |
| 01/07/2010 | WO2009140448A8 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 01/07/2010 | US20100003256 Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders |
| 01/07/2010 | CA2728219A1 Diglycidic ether derivative therapeutics and methods for their use |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2139480A1 Ranolazine for enhancing insulin secretion |
| 01/06/2010 | EP1575938B1 Compounds having selective inhibiting effect at gsk3 |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 12/31/2009 | US20090326248 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325900 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/31/2009 | US20090324753 Product and composition for alleviating post-menstrual symptoms |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/30/2009 | WO2009158415A1 Octreotide implant having a release agent |
| 12/30/2009 | WO2009158412A2 Sustained delivery of exenatide and other polypeptides |
| 12/30/2009 | WO2009158007A2 Methods and compositions for therapeutic treatment |
| 12/30/2009 | WO2009134380A3 Super fast-acting insulin compositions |
| 12/30/2009 | EP2138497A1 Novel adenine compound |
| 12/30/2009 | EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria |
| 12/30/2009 | EP2137531A2 Biased ligands for receptors such as the pth receptor |
| 12/30/2009 | EP2137213A1 Methods and compositions for treating prostate cancer |
| 12/30/2009 | EP1989218B1 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 12/30/2009 | EP1242012B1 Improved transdermal contraceptive delivery system and process |
| 12/30/2009 | EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof |
| 12/30/2009 | CN100574801C Liquid growth hormone formulation |
| 12/30/2009 | CA2729139A1 Octreotide implant having a release agent |
| 12/30/2009 | CA2728735A1 Compositions and methods for enhanced somatostatin immunogenicity |
| 12/29/2009 | US7638607 Urocortin proteins and uses thereof |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638508 Glucocorticosteroid compound having anti-inflammatory activity |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/24/2009 | US20090318514 Novel Pharmaceutical Compositions |